Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Dolan

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Cancer Research|December 5, 2000
O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat gliomaL D Rhines, P Sampath, M E Dolan, et al.
Carcinogenesis|September 1, 1989
Expression of mammalian O6-alkylguanine-DNA alkyltransferase in a cell line sensitive to alkylating agentsM E Dolan, L Norbeck, C Clyde, et al.
Journal of Medicinal Chemistry|January 20, 1995
8-Substituted O6-benzylguanine, substituted 6(4)-(benzyloxy)pyrimidine, and related derivatives as inactivators of human O6-alkylguanine-DNA alkyltransferaseM Y Chae, K Swenn, S Kanugula, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
The effects of O6-benzylguanine and hypoxia on the cytotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea in nitrosourea-resistant SF-763 cellsA Sarkar, M E Dolan, G G Gonzalez, et al.
Cancer Research|October 18, 2000
Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferasesY Cai, M H Wu, M Xu-Welliver, et al.
Journal of Medicinal Chemistry|February 4, 1994
Substituted O6-benzylguanine derivatives and their inactivation of human O6-alkylguanine-DNA alkyltransferaseM Y Chae, M G McDougall, M E Dolan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Sequential therapy with dacarbazine and carmustine: a phase I studyR B Mitchell, M E Dolan, L Janisch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivoS J Chmura, M E Dolan, A Cha, et al.
Mutation Research|September 1, 1991
Effect of O6-alkylguanine-DNA alkyltransferase on the frequency and spectrum of mutations induced by N-methyl-N'-nitro-N-nitrosoguanidine in the HPRT gene of diploid human fibroblastsL L Lukash, J Boldt, A E Pegg, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Peripheral blood mononuclear cell dihydropyrimidine dehydrogenase activity in volunteers with and without diabetes mellitusG F Fleming, E E Vokes, J B Buse, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Cancer Research|December 5, 2000
O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat gliomaL D Rhines, P Sampath, M E Dolan, et al.
Carcinogenesis|September 1, 1989
Expression of mammalian O6-alkylguanine-DNA alkyltransferase in a cell line sensitive to alkylating agentsM E Dolan, L Norbeck, C Clyde, et al.
Journal of Medicinal Chemistry|January 20, 1995
8-Substituted O6-benzylguanine, substituted 6(4)-(benzyloxy)pyrimidine, and related derivatives as inactivators of human O6-alkylguanine-DNA alkyltransferaseM Y Chae, K Swenn, S Kanugula, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
The effects of O6-benzylguanine and hypoxia on the cytotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea in nitrosourea-resistant SF-763 cellsA Sarkar, M E Dolan, G G Gonzalez, et al.
Cancer Research|October 18, 2000
Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferasesY Cai, M H Wu, M Xu-Welliver, et al.
Journal of Medicinal Chemistry|February 4, 1994
Substituted O6-benzylguanine derivatives and their inactivation of human O6-alkylguanine-DNA alkyltransferaseM Y Chae, M G McDougall, M E Dolan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Sequential therapy with dacarbazine and carmustine: a phase I studyR B Mitchell, M E Dolan, L Janisch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivoS J Chmura, M E Dolan, A Cha, et al.
Mutation Research|September 1, 1991
Effect of O6-alkylguanine-DNA alkyltransferase on the frequency and spectrum of mutations induced by N-methyl-N'-nitro-N-nitrosoguanidine in the HPRT gene of diploid human fibroblastsL L Lukash, J Boldt, A E Pegg, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Peripheral blood mononuclear cell dihydropyrimidine dehydrogenase activity in volunteers with and without diabetes mellitusG F Fleming, E E Vokes, J B Buse, et al.
Pageof 12